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Abstract
Although general anesthetics are known to modulate the activity of ligand-gated ion channels in the Cys-loop superfamily,
there is at present neither consensus on the underlying mechanisms, nor predictive models of this modulation. Viable
models need to offer quantitative assessment of the relative importance of several identified anesthetic binding sites.
However, to date, precise affinity data for individual sites has been challenging to obtain by biophysical means. Here, the
likely role of pore block inhibition by the general anesthetics isoflurane and propofol of the prokaryotic pentameric channel
GLIC is investigated by molecular simulations. Microscopic affinities are calculated for both single and double occupancy
binding of isoflurane and propofol to the GLIC pore. Computations are carried out for an open-pore conformation in which
the pore is restrained to crystallographic radius, and a closed-pore conformation that results from unrestrained molecular
dynamics equilibration of the structure. The GLIC pore is predicted to be blocked at the micromolar concentrations for
which inhibition by isofluorane and propofol is observed experimentally. Calculated affinities suggest that pore block by
propofol occurs at signifcantly lower concentrations than those for which inhibition is observed: we argue that this
discrepancy may result from binding of propofol to an allosteric site recently identified by X-ray crystallography, which may
cause a competing gain-of-function effect. Affinities of isoflurane and propofol to the allosteric site are also calculated, and
shown to be 3 mM for isoflurane and 10 mM for propofol; both anesthetics have a lower affinity for the allosteric site than
for the unoccupied pore.
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Introduction
Despite more than a century of research [1,2], open questions
remain regarding the molecular mechanism by which anesthetics
modulate signal transmissions in the central nervous system (CNS).
Electrophysiology and photolabeling have demonstrated that
general anesthetics bind to the Cys-loop superfamily of pentameric
ligand-gated ion channels. [3–5]. Several high resolution crystal
structures have helped decipher the binding modes of anesthetics
to proteins [6–9]. Only recently, however, did crystal structures
[10] of the general anesthetics desflurane and propofol in complex
with a prokaryotic member of the superfamily (GLIC) appear,
providing an atomic-level basis to the ‘‘direct binding’’ hypothesis
for modulation of Cys-loop receptors by general anesthetics.
Several open questions cannot be addressed by crystallography
alone, however, including energetics of binding, the possible role
of pore block (due to detergents lodged in the pore during
crystallization), and the molecular mechanism by which binding to
allosteric sites modulates function. Potential differences in binding
modes between prokaryotic and eukaryotic channels further
complicates interpretation of results. Consequently, a full under-
standing of the physical mechanism through which binding of
anesthetics to Cys-loop ion channels affects ion permeation
remains elusive, despite numerous experimental [4,10–19] and
computational [20–26] studies.
Ligand-gated ion channels in the Cys-loop receptor superfamily
are sensitive to general anesthetics at clinical concentrations
[4,14]; in general, excitatory cationic channels are inhibited by
general anesthetics, while inhibitory anionic channels are poten-
tiated. Members of this superfamily include the anion permeable
glycine and c-aminobutyric acid type A (GABAA) receptors, as
well as the cation permeable serotonin (5-HT3) and nicotinic
acetylcholine (nAChR) receptors. A cation channel in the Cys-loop
family from the bacteria Gloeobacter violaceus (GLIC) has been
crystallized at atomic resolution (2.9 and 3.1 A ˚) in a putatively
open state [27,28]. While gated by protons rather than neuro-
transmitters, GLIC retains a large amount of structural similarity
with Cys-loop receptors including the pentameric symmetry, an
extracellular domain (ECD) with a predominantly beta structure,
and four transmembrane alpha helices (M1–M4) per subunit.
Patch clamp experiments revealed that a diverse group of
molecules, including both injected and inhaled anesthetics, inhibit
GLIC at subclinical concentrations [10,29]. An additional
structure for the Glutamate-gated anion channel from C. Elegans
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this channel has not been reported.
Information regarding anesthetic binding sites within Cys-loop
receptors has been obtained from molecular biology [11,12],
photoaffinity labelling [15–17], and NMR [13,18,19] experiments.
X-ray structures of GLIC indicate an intra-subunit site for both
volatile (desflurane) and injected (propofol) anesthetics in the outer
part (extracellular side) of the transmembrane domain (TMD)
[10]. No general anesthetic has been resolved in the transmem-
brane pore, but this may be precluded by binding of detergents
(dodecylmaltoside, DDM) within the pore [27]. In one case, a
brominated variant of the local anesthetic lidocaine has been
detected inside the GLIC pore in a crystal structure by Hilf et al.
[31] (PDB accession code 2XQ3). Only the large electron density
of the bromine atom could be resolved, and its location indicates a
binding mode for bromo-lidocaine that is compatible with binding
of a bundle of DDM molecules (Supporting Figure S3). Results
from electrophysiology [32], mutagenesis [11], and photoaffinity
labeling [17] are consistent with occupation of the eukaryotic Cys-
loop pore by anesthetics. Furthermore, in recent atomistic
molecular dynamics (MD) simulations by our group [24], which
identified several anesthetic binding sites for isoflurane in both
nAChR and GLIC using long-time molecular dynamics for a
flexible dock (‘‘flooding’’), two isoflurane molecules bound stably
for 300 ns to the pores of both GLIC and nAChR. Similarly, a
single isoflurane was observed to bind to the GLIC pore in Ref.
[26]. Since there are significant expected ramifications of pore
block for inhibition of ion channel function, it is difficult to discern
the role of other allosteric sites without consideration of the
potential for pore block at any concentrations at which inhibition
is observed.
Due to the multitude [15,22,24,25,31,33,34] of binding sites in
eukaryotic receptors indicated by both experiments and simula-
tion, untangling the molecular mechanism of action requires a
method for ranking detected sites according to their affinity and
implications for channel function. Isolating individual sites remains
unfeasible in experiments, and any measured affinities would
reflect an average over multiple unknown sites. Computer
simulations offer several techniques for calculating binding
affinities for given anesthetics in individual binding pockets. One
method, known as alchemical free energy perturbation (FEP), has
been developed to obtain absolute binding free energies from MD
simulations [35,36]. FEP has already been used to calculate
affinities for isoflurane binding to apoferritin that compare well to
experiment [37], and used to characterize several potential
binding sites for halothane on a neuronal nAChR [22]. Recent
advances in computational techniques and resources have made
the reliable calculation of binding affinities in systems as large as
Cys-loop receptors feasible. Since FEP-MD simulations require
high-resolution protein structures as input, GLIC serves as the
most structurally relevant model for analyzing the energetics of
anesthetic binding, and for probing a pore block event in detail.
In this article, we present an extensive quantitative FEP study of
inhaled and injected anesthetics bound to the GLIC pore,
considered primarily in the context of a pore-block mechanism.
In over 1.5 microseconds of atomistic simulations, we calculate
binding affinities for monomers and dimers of isoflurane and
propofol for comparison with dose response curves from electro-
physiology. The affinity of ethanol (which does not affect GLIC at
mM concentrations) is also calculated as a negative control [29].
An analytical model for relating microscopic and macroscopic
parameters of binding is presented and used to demonstrate that a
pore-block model is sufficient to predict the effect of isoflurane on
GLIC. Results from FEP calculations of propofol binding to GLIC
are consistent with a model in which propofol blocks the pore at
concentrations less than the IC50, suggesting that the allosteric site
observed in X-ray structures [10] may cause a competing
potentiation effect.
Results
Evolution of the pore region
In control simulations of GLIC without anesthetics, a section of
the pore comprising the hydrophobic gate (ILE232–ILE239) tends
to constrict slightly over time, which is coupled to breaking of the
water column. Spontaneous closure of the pore has also been
recently reported in simulations of GLIC with isoflurane, where the
pore dehydrated between the gating isoleucines prior to isoflurane
binding to the dry ion channel [38]. Although fluctuations in pore
width and hydration are to be expected, spontaneous recovery of
the open pore conformation was not observed. Systematic closure
under simulation suggests that the crystal structure could be more
open than typical of the open state, whereas our MD-equilibrated
conformations, conversely, seem too constricted to represent an
open channel. As a result, it is unclear what conformations are most
relevant to the channel’s physiological open state. Since large-scale
conformational fluctuations cannot be reliably sampled in atomistic
simulations, independent simulations were performed to sample
both the open-pore and closed-pore conformational basins.
Simulations of the closed-pore receptor started from the final
configurationof the unrestrained control simulation,where the pore
is dehydrated. To simulate the open pore, a set of restraints was
designed to prevent closure while minimizing sampling bias within
the open-pore basin (see Methods for details).
Dynamics of bound anesthetic
Distributions of the anesthetic molecules’ positions along the
pore axis (Figures 1–2) indicate a primary binding site between
ILE232 and ILE239 (99 and 169) for both isoflurane and propofol.
This location within the pore corresponds to that observed in
crystal structures for the bromine atom of bromo-lidocaine [31] as
well the hydrophobic tails of crystallization detergents [27]
(Supporting Figure S3). A secondary site is observed between 69
and 99 for both isoflurane and propofol, with another secondary
site observed between 169 and 209 for propofol bound to the
closed-pore conformation.
Author Summary
Although general anesthesia is performed every day on
thousands of people, its detailed microscopic mechanisms
are not known. What is known is that general anesthetic
drugs modulate the activity of ion channels in the central
nervous system. These channels are proteins that open in
response to binding of neurotransmitter molecules,
creating an electric current through the cell membrane
and thus propagating nerve impulses between cells. One
possible mechanism for ion channel inhibition by anes-
thetics is that the drugs bind inside the pore of the
channels, blocking ion current. Here we investigate such a
pore block mechanism by computing the strength of the
drugs’ interaction with the pore – and hence the likelihood
of binding, in the case of GLIC, a bacterial channel protein.
The results, obtained from numerical simulations of atomic
models of GLIC, indicate that the anesthetics isoflurane
and propofol have a tendency to bind in the pore that is
strong enough to explain blocking of the channel, even at
low concentration of the drugs.
Pore Block by General Anesthetics
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than for propofol, indicating a looser fit for both primary and
secondary sites that is consistent with the relative sizes of the two
molecules. Timescales for exchange and hopping among sites are
also decreased for isoflurane: exchange between sites was observed
in the isoflurane simulations but not the propofol simulations.
Figure 2 indicates that secondary sites for propofol had either an
occupancy of about 1 or 0 over the course of these simulations,
which is consistent with a relatively simple model in which
propofol can bind to 2–3 distinct binding sites in the pore.
The same picture cannot be applied to isoflurane. A single
isoflurane bound to the closed pore conformation spends similar
amounts of time in the primary and secondary site with fractional
occupancy (less than 1) in each. The addition of a second
isoflurane increases density in the primary site, with occupancy
greater than 1 in the primary site and slight increases in occupancy
of the secondary site. Therefore, two isoflurane molecules will
spend a large fraction of time with the appearance of a dimer, with
both molecules in the same local free energy minima, and a small
fraction of time in separate minima. This results holds for both
pore conformations, although in the closed-pore conformation the
dimer is more frequently oriented along the z-axis, as evident by
the shoulder on the primary peak; the open-pore primary site has
sufficient radius for two isoflurane molecules to occupy similar
positions along the z-axis (see, e.g. Figure 1).
During a similar 100 ns traditional simulation of ethanol initially
bound to the pore, ethanol exited and re-entered the pore several
times, consistent with the low affinities measured by FEP
calculations and the absence of effect in electrophysiological studies.
Predicted binding affinities
Calculated values for K1 and K2 are shown in Table 1, with
contributions from various terms shown in Table 2. Propofol has a
substantially stronger affinity than isoflurane for all binding sites
probed (pore single occupancy, pore double occupancy, and
allosteric site). The affinity of ethanol (pore single occupancy) was
the weakest measured and indicates negligible binding of ethanol to
the pore. The ranking of pore affinities is therefore Propo-
folwIsofluranewEthanol, which is the same hierarchy as the GLIC
IC50, solubility in olive oil, and minimum alveolar concentration
(MAC) of these compounds. For propofol and isoflurane, the trend
holds for both pore and allosteric sites, suggesting a limited role for
such trends in distinguishing among potential mechanisms.
The affinity of isoflurane for the allosteric site (2.8 mM) suggests
relatively weak binding. Broad dose-response curves for GLIC
exposed to isoflurane [29], however, indicate that saturation
requires concentrations of at least 1 mM; therefore binding of
isoflurane to the allosteric site may still contribute to dose response.
Measured affinities of isoflurane for the pore sites (2:9{620 mM,
depending on occupancy numberand conformationof the pore)are
substantially stronger, indicating that at IC50~60 mM pore-block is
a very likely mechanism of inhibition of GLIC by isoflurane.
Measured affinity of propofol for the allosteric site (9:4 mM)
suggests that the allosteric site observed in X-ray structures [10]
will likely be occupied at IC50~24 mM. However, like isoflurane,
affinity of propofol for the pore sites (0:38{4:0 mM) is substan-
tially larger than affinity for the allosteric site. This result is not
inconsistent with crystallographic data given that binding of
detergents to the pore during crystallization would have prevented
observation of pore block by propofol in X-ray structures.
The pore is expected to undergo fluctuations under physiolog-
ical conditions. The open-pore and closed-pore conformations
represent the extremes of this conformational range. Lacking more
precise information on the most likely conformations, we calculate
affinities for both of these conformations to obtain ranges of
possible values. Binding of isoflurane to the pore is strongly
Figure 1. Anesthetic binding sites under investigation. Left: View of the GLIC channel with two propofol molecules blocking a pore restrained
to be open (shown in red and orange), and one bound in the crystallographic binding site (purple). Center: The two propofol molecules bound to the
pore formed by M2 helices (gray). Right: Analogous magnification of two isoflurane molecules in the pore. Isoleucines bounding the hydrophobic
gate (I232 and I239) are shown in cyan. To reveal the pore interior, only four of the five GLIC subunits are shown. An analogous image for the closed
conformation is shown in Supporting Figure S1.
doi:10.1371/journal.pcbi.1002532.g001
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pore conformation are substantially stronger than both affinities
measured for the open-pore conformation. As detailed in the
following section, this limits precision in predictions of exper-
imental IC50 for isoflurane based on a pore-block model alone.
The mechanism of propofol binding to the pore appears to be at
most weakly conformation-dependent, with affinities for the open
pore within error bars of affinities for the closed pore.
Table 1 indicates that binding of isoflurane to the pore is
negatively cooperative for the closed-pore conformation (K1vK2)
and non-cooperative for the open-pore conformation (K1*K2).
Density of the second isoflurane molecule is found mostly in the
primary site, so these results imply that binding of one isoflurane
molecule to the whole pore affects the binding of additional
molecules to the primary site more strongly in the closed pore than
the open pore; this result correlates with the reduced volume
available to a dimer in the closed pore relative to the open pore.
Affinities of propofol for the pore indicate a binding mechanism
that is at most weakly negatively cooperative. Binding to the
secondary site when the primary site is already occupied is therefore
nearly as favorable as binding to the primary site of an empty pore.
This may not be the case when the primary site is unoccupied;
however, as previously discussed, sampling limitations preclude us
from drawing conclusions about relative affinities for the primary
and secondary sites for propofol from Figure 2.
GLIC is not sensitive to ethanol at concentrations ranging up to
200 mM [29], making it a convenient negative control. A single
molecule of ethanol was placed in the GLIC pore, and its affinity
was calculated as 510 mM, which is consistent with the absence of
an effect at lower concentrations. Furthermore, in 100 ns standard
MD simulations (non-FEP), the ethanol molecule left the pore,
which was not observed in simulations involving either isoflurane
or propofol. The results of this negative control suggest that our
computational approach for determining strong binding is
selective for true high-affinity ligands.
Prediction of IC50 from microscopic parameters
Relating these microscopic parameters to macroscopic proper-
ties of the dose-response curve such as the half-maximal
concentration (IC50) required development of a modified model
for dose response due to pore block.
The present model accounts for the possibility that a single
anesthetic molecule might not be bulky enough to cause a full
block, especially given the observed mobility of smaller anesthetics
in the pore. The fractional inhibition F due to pore block by a
monomer or dimer can then be described by a modified Adair
equation:
F~
aK2½X z½X 
2
K1K2zK2½X z½X 
2 , ð1Þ
Table 1. Predicted binding affinities and experimental IC50.
K1 K2 Predicted IC50
* IC50
Anesthetic Binding Site (mM)( mM)( mM)( mM)
Isoflurane Pore(closed) 2.9 83 2.8–86 60
Isoflurane Pore(open) 620 530 370–890 60
Isoflurane Allosteric 2,800
Propofol Pore(closed) 0.46 1.8 0.38–2.1 24
Propofol Pore(open) 1.5 2.9 1.1–4.0 24
Propofol Allosteric 9.4
Ethanol Pore(closed) 7.1|105
Binding affinities based on free energies presented in Table 2.
*Range of predicted IC50 corresponds to model parameter a varying from 0
(higher IC50) to 1 (lower IC50).
Table 2. Detail of calculated free energies of binding
anesthetics to GLIC.
Anesthetic Binding Site DGsolv DGsym DGrestr DG1 DG2
Isoflurane Pore(closed) 20.2 0 20.3 27.6+0.2 25.6+0.4
Isoflurane Pore(open) 20.2 0 20.3 24.4+0.9 24.5+0.7
Isoflurane Allosteric 20.2 0 20.7 23.5+0.3 –
Propofol Pore(closed) 21.5 0.4 20.3 28.7+0.2 27.9+0.9
Propofol Pore(open) 21.5 0.4 20.3 28.0+0.6 27.6+1.2
Propofol Allosteric 21.5 0.4 20.7 26.9+0.2 –
Ethanol Pore(closed) 24.6 0.4 20.3 20.2+0.3 –
Absolute binding free energies calculated according to Equations 2 and
Equations 5. All data expressed in kcal/mol. Error bars correspond to the
standard error based on the difference between the recoupling and decoupling
calculations.
doi:10.1371/journal.pcbi.1002532.t002
Figure 2. Density distribution of anesthetic molecules in the
GLIC pore. Density for one anesthetic bound (dashed) and two
anesthetics bound (solid), defined by r(z)~nP(z), where n is the
number of anesthetics in the pore and P(z) is the probability of
observing the anesthetic center of mass in the bin centered around z.
Curves have been smoothed by a three-bin-wide running average. Red:
data for the closed pore, black: data for the open pore.
doi:10.1371/journal.pcbi.1002532.g002
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probability of pore block by a monomer (it is assumed that the
probability of pore block by a dimer is 1). Furthermore, the
dissociation constants for binding of the first ligand and the second
ligand, are, respectively:
K1~
½X ½M 
½MX1 
~C0 exp(DG1=RT) ð2Þ
K2~
½X ½MX1 
½MX2 
~C0 exp(DG2=RT), ð3Þ
where ½M  is the concentration of receptors with no anesthetic
bound, ½MX1  is the concentration of receptors with 1 anesthetic
bound, and ½MX2  is the concentration of receptors with 2
anesthetics bound, and C0~1M . The difference between the
present and other more traditional treatments lies primarily in the
use of a to capture the unknown relationship between occupancy
and function.
For ½X ~IC50, F~1=2,s o
IC50~{K2 a{
1
2
  
z
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
K2
2 a{
1
2
   2
zK1K2
s
, ð4Þ
simplifying to IC50~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
K1K2
p
in the special case a~1=2. Using K1
and K2 measured from FEP calculations and the upper and lower
bounds on physical values of a (0 to 1), we predict an IC50 range
for isoflurane and propofol (Table 1).
Based on a pore-block model alone, predicted IC50 for
isoflurane lies in the range 350{850 mM for the open-pore
conformation and 2.6–81 mM for the closed-pore conformation.
The experimental value of 60 mM, therefore, falls within the range
of IC50 values predicted for these two conformational extremes,
although a precise prediction is not feasible due to the uncertainty
in the physiological conformation. Only block of functionally open
channels is relevant for current inhibition, but the indirect
correlation between these extreme structural states and various
functional states precludes the simple discounting of the closed-
pore conformation. The results do indicate that if the relevant
physiological state is more constricted, the IC50 is likely to be
larger than if it is more open.
An additional allosteric binding site for the general anesthetics
desflurane and propofol in GLIC has been identified using X-ray
crystallography [10], although no such site was identified for
isoflurane. According to FEP calculations, the affinity of isoflurane
for this allosteric site is 270 mM, which is weaker than either pore
site in either conformation. Dose-response data indicates that
saturation, however, requires isoflurane concentrations greater
than 1000 mM, suggesting that the site identified in Ref. [10] will
still contribute towards modulation at high concentrations.
Predicted IC50 for propofol ranges from 0:5{1:8 mM for the
open-pore conformation and from 2:6{81 mM for the closed pore
conformation. The pore sites are therefore predicted to be of high
affinity, and will likely be occupied at most experimentally
accessed concentrations. However, the experimental IC50 for
propofol is 24 mM [10] and lies outside the predicted range for all
a, for both closed-pore and open-pore conformations, indicating
that a pore-block model alone overestimates the inhibitory effects
of propofol. An additional allosteric propofol binding site has been
observed in the center of the helical bundles via X-ray
crystallography [10].
Discussion
We have measured microscopic parameters of a potential pore-
block mechanism by which inhaled and injected anesthetics inhibit
the prokaryotic pentameric ion channel GLIC.
Two sets of simulation conditions were applied: unrestrained
conditions under which the transmembrane pore is slightly
constricted and hence dehydrated, and restrained conditions
preventing such closure and keeping the pore opening similar to
that of the crystal structures. To date, there are no reports of
unrestrained simulations of GLIC modeled using the CHARMM
forcefield in which the pore maintains its crystallographic shape
for longer than 25 ns. Possible explanations include limitations of
the molecular model, particularly protonation of titratable residues
involved in GLIC opening at low pH. Simulation models that
allow for fluctuating protonation states are still cumbersome,
particularly when many titratable residues are involved.Recently,
GLIC was simulated for 200 ns without observed pore collapse
[39], using the Amber03 [40] forcefield and the Gromacs software
package [41] (The relevant differences between the two approach-
es have not yet been not been conclusively determined.
Performance of CHARMM22/CMAP in tests to detect a native
state in an ensemble of potential protein structures is comparable
to that of AMBER03 [40].
The extent of the instability is therefore surprising, and may also
stem from the presence of six molecules of the detergent DDM in
the hydrophobic segment of the pore in at least one crystal (3EAM
[27], resolution 2.9 A ˚); these detergent molecules are not included
in most simulations. While other crystal structures for GLIC
(including 3EHZ [28], resolution 3.1 A ˚) do not include resolved
detergents in the pore, this may reflect the limited resolution of
those structures. As a control, structures were determined by
Bocquet et al. [27] from crystals in which DDM is replaced with
bulkier brominated analogues. The results indicate that pore
occupancy by detergent is reduced, not eliminated, and bound
detergent is more disordered. Therefore, the pore conformation
resolved crystallographically has not been shown to be indepen-
dent of occupancy by detergent; this could contribute to the
tendency of the empty pore to close in simulations.
A consequence of the likely pore occupancy by crystallization
detergent is that little insight into a pore block mechanism can be
provided by crystallographic means. Unlike bromo-lidocaine,
which has a binding site in the pore [31] that has only partial
overlap with that observed for DDM, general anesthetics are
predicted to bind to the hydrophobic outer half of the
transmembrane pore. The main site, between 99 and 169, is fully
obstructed by the bundle of DDM molecules (Supporting Figure
S3) resolved by Bocquet et al. [27] Therefore, current crystalli-
zation conditions for GLIC seem not to be compatible with
general anesthetic binding as discussed here.
Both isoflurane and propofol are predicted to bind to the pore
as dimers; higher-order aggregates were not investigated since they
were not observed in isoflurane ‘‘flooding’’ simulations [24].
Microscopic affinities of one and two anesthetic molecules are
calculated using the explicit, formally exact Alchemical Free
Energy Perturbation method, and a new analytical model is
developed to relate the microscopic affinities to the dose response,
including the IC50 value. The model includes the free parameter
a, which describes the probability that a single anesthetic will block
the pore.
Calculated affinities for isoflurane are highly dependent on pore
conformation (Table 1), yielding predicted values of IC50 spanning
a 300-fold range (2.9 to 890 mM), while the experimental value of
IC50 is 60 mM. The best agreement with experiment is obtained
Pore Block by General Anesthetics
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assuming that two isoflurane molecules are required to block the
pore (a&0). The predicted millimolar affinity of isoflurane for the
allosteric site is consistent with the absence of crystal structures
resolving isoflurane in the allosteric site. The results, while
quantitatively ambiguous due to the uncertainty surrounding
details of the GLIC pore structure, are compatible with inhibition
of GLIC by isoflurane through pore block.
Propofol is also shown to bind with high affinity to the pore, but
a model based on pore block alone overestimates the inhibitory
effects of propofol, predicting an IC50 that is at least an order of
magnitude lower (0:4{4 mM) than that measured experimentally
(24 mM). Furthermore, affinity of propofol for the allosteric site
observed in crystal structures is 9 mM, suggesting that both pore
and allosteric sites will be occupied over a range of concentrations.
In this low concentration domain, a population of receptors will
have an allosteric site occupied without block of the pore. We
hypothesize that these receptors may actually be potentiated,
reducing the observed net inhibition caused by pore block and
thereby increasing the apparent IC50. Such competing effects may
explain why propofol dose response is not well described by a
Monod-Wyman-Changeux model.
This proposed model is consistent with a current model for
competing effects in the nicotinic Acetylcholine Receptor and at
super-clinical anesthetic concentrations in the GABAA receptor
[17]. Due to the possibility that binding to the intrasubunit
allosteric site could cause either gain or loss of function,
interpreting mutagenesis results such as those reported with the
crystal structure in Ref. [10] becomes challenging: observed
reduction in the IC50 could result from a mutation that causes a
higher affinity for a negative modulator or lower affinity for a
positive modulator. Given such ambiguities, photoaffinity labeling
of GLIC with azi-propofol [42] or azi-isoflurane [43] in the
presence and absence of known GLIC channel blockers [44,45]
may provide the most straightforward experimental test of a pore-
block mechanism. This work highlights the subtleties involved in
interpreting global functional measurements when competing
binding sites are likely.
The ranking of pore affinities corresponding to rankings in
GLIC IC50, solubility in olive oil, and minimum alveolar
concentration (MAC) of these compounds, with propo-
folwisofluranewethanol. Most known anesthetics follow the
classic Meyer-Overton [1,2] correlation that linearly relates
MAC to solubility in olive oil; this correspondence can be
extended to exclude non-immobilizers when lipophilicity is
substituted by affinity for the hydrophobic-polar interface [46].
The GLIC pore contains both hydrophobic and polar residues,
forming an interfacial environment which will likely bind a wide
range of amphipathic general anesthetics, as well as charged local
anesthetics and other blockers [44,45]. The GABAA receptor
transmembrane pore is noticeably less hydrophobic at the location
where we predict anesthetic binding: this could result in a lower
affinity for anesthetic and the lack of clinically significant pore
block in the GABAA receptor: such a difference would be crucial
in explaining the opposing effects of general anesthetics on
inhibitory and excitatory receptors.
Use of conformational restraints on the pore in some of the
present affinity calculations aims at probing two end-points within
a conformational ensemble, in the absence of reliable knowledge
of the actual conformational distribution forming the open state of
GLIC. This approach is vindicated by the propofol results, which
prove insensitive to the restraints, or lack thereof. Therefore, the
predicted propofol affinities are the main, unambiguous basis to
our hypothesis of counteracting effects between sites. In contrast,
isoflurane binding is more sensitive to the pore conformation, and
the experimental IC50 falls between those predicted from the two
conformational extremes. Thus the isoflurane affinities for the
pore are obtained with a significant margin of uncertainty, and
should be regarded merely as an argument for continued
plausibility of pore block as a potential mechanism for modulation
by isoflurane.
Although historically, pore block has not been widely discussed as
a potential molecular mechanism for the action of general
anesthetics, periodic results from electrophysiology [32], mutagen-
esis [11], photoaffinity labeling [17], and simulation [24,26] have
suggested the pore as a site for inhibition by anesthetics in
eukaryotic Cys-loop receptors. The simulations in the present work
offer quantitative results regarding the affinities of general
anestheticsforthepore ofa ligand-gated ionchannel;therobustness
of this finding lead us to propose pore block as a significant
mechanism for channel inhibition by general anesthetics.
Methods
System setup
Initial GLIC coordinates were taken from the 3EAM structure,
and prepared in a similar manner to previous studies of GLIC
[24,27]. GLIC was protonated according to the Henderson-
Hasselbalch relationship with the pKa results given in Ref. [27],
and protonation states on ionizable residues assigned assuming a
pH of 4.6. The protein was placed in a pre-equilibrated 1-
palmitoyl-2-oleoyl-sn-glycerol-phosphatidylcholine bilayer that
was originally created with the MEMBRANE plugin of VMD
[47]. Following protein insertion, the individual anesthetics were
placed into either the pore or the site determined by X-ray crystal
structure. To place anesthetics in the channel itself, the center of
mass (COM) of the anesthetic was moved with a random
orientation to overlap with the COM of the pore. Here, we
identify the COM of the pore as the COM of the Ca atoms of
residues Tyr226 and Tyr244. For the anesthetics placed in the X-
ray site, the COM of individual anesthetics were moved to overlap
with the COM of the Ca atoms defined as the boundary of the
binding site from the residues on M1, M3, M4, and the b6–b7
loop given in Ref [10]. After the anesthetics were placed in the
binding site, the system was solvated using the SOLVATE
command in VMD, and NaCl was added to bring the salt
concentration to 0.15 M. In the end, system was comprised of
roughly 200,000 atoms including water, protein, membrane, ions,
and anesthetics.
Simulation details
Ten thousand steps of minimization were run to remove any bad
initial contacts, followed by 2 ns of equilibration in which both
protein and anesthetic were harmonically restrained with a 5 kcal/
mol/A ˚ force constant to their initial positions. This allowed the
membrane and aqueous solution to relax around the protein-
anesthetic complex. A second 2 ns simulation was run where only
the anesthetic was positionally restrained, yet all other atoms
includingthoseintheprotein,wererelaxed aroundit.Followingthis
equilibration process, a simulation was run for between 50–100 ns
for each of the eight systems shown in Figure 2, with flat-bottom
pore restraints (described below) on the ‘‘open-pore’’ simulations. In
total, including a 300 ns control simulation with no anesthetics, the
traditional MD systems required 1.2 ms of aggregate simulation
time, and the ending coordinates of these simulations were used as
input to their corresponding FEP calculations.
All simulations used the CHARMM22-CMAP force field with
torsional corrections for proteins [48,49]. The CHARMM27 [50]
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parameters were taken from the CHARMM35 model [51], while
parameters previously developed in our group were used for
isoflurane. New CHARMM-consistent force field parameters for
propofol were developed for this study. All parameters can be
found in Supporting Dataset S1 and Supporting Dataset S2 and a
description of the parameterization process can be found in
Supporting Text S1. Energy minimization and MD simulations
were made by the NAMD2.7b2 package [52]. All simulations
employed periodic boundary conditions, long-ranged electrostatics
were handled with the smooth particle mesh Ewald method [53],
and a cutoff of 1.2 nm was used for Lennard-Jones potentials with
a smoothing function applied starting at 1.0 nm. All simulations
were run in the NPT emsemble with weak coupling to a Langevin
thermostat and barostat at a respective 300 K and 1 atm. All
bonds to hydrogen atoms were constrained using the SHAKE/
RATTLE algorithm. A multiple timestep rRESPA method was
used, and controlled with a high-frequency timestep of 2 fs and a
low-frequency timestep of 4 fs. RMSD plots are shown in
Supporting Figures S4 and S5.
Pore restraints
Closing of the pore was found to be well-described by pairwise
distances between M2 helices across the pentamer. For each M2
helix, the geometric center of alpha carbon atoms in the
extracellular half (residues ILE232 to LEU245) was determined.
Five distances di between these centers were calculated, between
all pairs of non-adjacent subunits: 1-3, 1-4, 2-4, 2-5, 3-2. Statistical
distributions of these distances from an unrestrained simulation
show two peaks: a smaller one corresponding to the metastable
open basin around 20 A ˚, and a larger population in the collapsed
state, at distances smaller than 19 A ˚. From the distributions, free
energy profiles may be extracted: although incomplete because of
insufficient sampling, they do give an indication about the shape of
the metastable open basin and the barrier separating it from the
collapsed state. (Supporting Figure S2) Based on this information,
we designed a ‘‘flat-bottom’’ restraint potential which enhances
the effect of the barrier and traps the pore in its open
conformation, without altering the energy landscape within the
open basin. The potential is zero for diw19:5A , and a harmonic
wall with a force constant of 10 kcal=mol=A
2 at smaller values of
di (Supporting Figure S2). Restraints were applied through the
Collective Variables module of NAMD [54].
FEP calculations
The total microscopic free energies of binding are
DG1~DGwater?vaczDG1
vac?prot{DGrestrzDGsym ð5Þ
DG2~DGwater?vaczDG2
vac?prot{DGrestrzDGsym, ð6Þ
where DGwater?vac~{DGsolv, DGsolv represents the solvation free
energy of the anesthetic, DGrestr represents the entropic cost of
imposing the restraints relative to the standard state volume,
DGsym is the penalty due to loss of symmetry upon binding [55],
DG1
vac?prot is the free energy required to move a single anesthetic
from vacuum into an unoccupied binding site, and DG2
vac?prot is
the free energy required to move a single anesthetic from vacuum
into a binding site already occupied by one anesthetic. DGwater?vac
varies for each anesthetic and was calculated using the protocol in
Ref. [37]. DG1
vac?prot and DG2
vac?prot require, by far, the most
calculation time. These values are measured, as in Ref. [37], by
successively decoupling and recoupling interactions between the
anesthetic and the protein/water/ion/other anesthetic environ-
ment, over a series of windows. For the systems with anesthetics in
the pore, flat-bottom cylindrical harmonic restraints were applied,
while flat-bottom spherical restraints were applied to keep
anesthetics in the X-ray binding site. For measurements of
DG2
vac?prot , only one anesthetic in the pore underwent recou-
pling/decoupling, while both were subject to a cylindrical
restraint. The force constants for both binding site restraints were
on the order of 10 kcal/mol/A ˚, and implemented in similar
fashion to methods used in our previous simulations of the binding
of isoflurane to apoferritin [37]. Due to the ‘‘square-well’’ shape of
the restraint, DGrestr is given purely by the entropic cost of
constraining the anesthetic within the bounds of the restraint
relative to a standard state solution:
DGrestr~RT ln
Vrestr
V1M
  
, ð7Þ
where Vrestr is the volume enclosed by the restraint and V1M is the
free volume the ligand would have in the standard state (a 1 M
solution). For calculations in the pore site, DGrestr~{0:3 kcal/
mol, while for calculations in the allosteric site,
DGrestr~{0:7 kcal=mol. DGsym for binding of A and B is equal
to RT ln
sAsB
sAB
  
where si is the symmetry number of species i
[55], in our case DGsym~ln(s), where s is one for isoflurane, and
two for propofol or ethanol. For the latter, the symmetry term
contributes 0.4 kcal/mol to binding free energies or a factor of two
in binding affinity.
In the present work the perturbation parameter l was sampled
with a step size equal to 0.025 between 0vlv0:1 and 0:9vlv1,
and 0.05 otherwise. Each step in l started with a 4 ps equilibration
period followed by a 1 ns run for data collection, and each
decoupling and recoupling stage required 25 ns of simulation. To
avoid the so-called ‘‘end point catastrophy’’, a soft-core potential
of Zacharias [35,36,56] was used, both electrostatics were
decoupled from each other during the FEP runs, and Lennard-
Jones potentials were shifted by 6.0 A ˚. Each system was decoupled
and recoupled once, requiring a total of 50 ns of FEP simulations
for each of the eleven systems, totaling to 0:55 ms of FEP data
overall. Free energies were estimated by combining the three
decoupling runs into one data set, the three recoupling runs into
one data set, and then combining backwards and forwards runs
using the Bennett acceptance ratio method [57]. However, the use
of the Bennett analysis method did not affect the results
significantly, relative to a simple averaging of free energies
measured from individual recoupling and decoupling stages.
Supporting Information
Dataset S1 Propofol parameter file in CHARMM for-
mat, including CMAP terms.
(TXT)
Dataset S2 Propofol topology file in CHARMM format.
(TXT)
Figure S1 Anesthetic binding sites in the unrestrained
pore conformation. Left: View of the GLIC channel with two
propofol molecules blocking an unrestrained pore (shown in red
and orange), and one bound in the crystallographic binding site
(purple). Center: Two propofol molecules in the pore formed by
M2 helices (gray). Right: Analogous magnification of two
Pore Block by General Anesthetics
PLoS Computational Biology | www.ploscompbiol.org 7 May 2012 | Volume 8 | Issue 5 | e1002532isoflurane molecules in the pore. Isoleucines bounding the
hydrophobic gate (I232 and I239) are shown in cyan. To reveal
the pore interior, only four of the five GLIC subunits are shown.
(TIF)
Figure S2 Design of the collective variable restraints.
Solid lines: Boltzmann transform of the distribution of the five
distances between M2 helices (see Methods) in an unbiased control
simulation. Dotted line: flat-bottom restraint potential applied to
confine the pore to the open basin.
(EPS)
Figure S3 Location of crystallographic DDM detergent
and bromo-lidocaine in the GLIC pore. M2 helices of GLIC
are shown as grey cylinders (one omitted for clarity), with
isoleucine residues 232 and 239 as cyan spacefill. DDM molecules
from structure 3EAM [27] are shown as sticks (one omitted for
clarity). Bromine atom of bromo-lidocaine from structure 2XQ3
[31] is shown as an orange sphere.
(TIF)
Figure S4 Root mean square deviations (RMSD) aver-
aged over all Ca atoms in the protein. Black lines represent
the open pore, red lines represent the closed pore, solid lines are
for the doubly occupied pore, and dashed lines are for the singly
occupied pore. For the closed pore occupied by a single isoflurane,
two trajectories have been used. In this case, one trajectory is given
as a dotted line and one by a dashed line.
(EPS)
Figure S5 Root mean square deviations (RMSD) aver-
aged over Ca atoms in the M2 helices. Black lines represent
the open pore, red lines represent the closed pore, solid lines are
for the doubly occupied pore, and dashed lines are for the singly
occupied pore. For the closed pore occupied by a single isoflurane,
two trajectories have been used. In this case, one trajectory is given
as a dotted line and one by a dashed line.
(EPS)
Text S1 Method for propofol parameterization.
(PDF)
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